Cargando…

Formulation and Optimization of Sustained Release Tablets of Venlafaxine Resinates Using Response Surface Methodology

The aim of the current study was to design sustained release matrix tablets of venlafaxine hydrochloride using ion exchange resin with the incorporation of hydrophilic and hydrophobic polymer combinations. Venlafaxine HCl was loaded onto Indion 244 by batch method and then resinate were wet granulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madgulkar, Ashwini R., Bhalekar, M. R., Kolhe, V. J., Kenjale, Y. D.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2009
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865810/ https://www.ncbi.nlm.nih.gov/pubmed/20502544 http://dx.doi.org/10.4103/0250-474X.57287

Ejemplares similares

Statistical Optimization of Sustained Release Venlafaxine HCI Wax Matrix Tablet
por: Bhalekar, M. R., et al.
Publicado: (2008)

Optimization of Carboxymethyl-Xyloglucan-Based Tramadol Matrix Tablets Using Simplex Centroid Mixture Design
por: Madgulkar, Ashwini R., et al.
Publicado: (2013)

Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
por: Momin, Munira M., et al.
Publicado: (2015)

Use of Response Surface Methodology in the Formulation and Optimization of Bisoprolol Fumarate Matrix Tablets for Sustained Drug Release
por: Malakar, Jadupati, et al.
Publicado: (2012)

Formulation Design, Optimization and Pharmacodynamic Evaluation of Sustained Release Mucoadhesive Microcapsules of Venlafaxine HCl
por: Swain, S., et al.
Publicado: (2014)

Formulation, evaluation and optimization of sustained release matrix tablets of captopril
por: Pandya, V. Pandya, et al.
Publicado: (2012)

Formulation and Optimization of Sustained Release Stavudine Microspheres Using Response Surface Methodology
por: Dey, Sanjay, et al.
Publicado: (2011)

Design, Development and Optimization of S (-) Atenolol Floating Sustained Release Matrix Tablets Using Surface Response Methodology
por: Gunjal, P. T., et al.
Publicado: (2015)

Modulation of Venlafaxine Hydrochloride Release from Press Coated Matrix Tablet
por: Gohel, M. C., et al.
Publicado: (2008)

Development of Buccal Adhesive Tablet with Prolonged Antifungal activity: Optimization and ex vivo Deposition Studies
por: Madgulkar, A., et al.
Publicado: (2009)

RP-HPLC Estimation of Venlafaxine Hydrochloride in Tablet Dosage Forms
por: Baldania, S. L., et al.
Publicado: (2008)

Tunable and sustained-release characteristics of venlafaxine hydrochloride from chitosan–carbomer matrix tablets based on in situ formed polyelectrolyte complex film coating
por: Zhang, Xiaofei, et al.
Publicado: (2018)

Chitosan-Montmorillonite Polymer Composites: Formulation and Evaluation of Sustained Release Tablets of Aceclofenac
por: Thakur, Garima, et al.
Publicado: (2015)

Investigation of the potential application of sodium bentonite as an excipient in formulation of sustained release tablets
por: Alkrad, Jamal Alyoussef, et al.
Publicado: (2017)

Fabrication and characterization of electrospun nanofibers using biocompatible polymers for the sustained release of venlafaxine
por: Hashem, Heba M., et al.
Publicado: (2022)

Response Surface Optimization of Sustained Release Metformin-Hydrochloride Matrix Tablets: Influence of Some Hydrophillic Polymers on the Release
por: Roy, Amitava, et al.
Publicado: (2012)

Formulation of Sustained Release Hydrophilic Matrix Tablets of Tolcapone with the Application of Sedem Diagram: Influence of Tolcapone’s Particle Size on Sustained Release
por: Nardi-Ricart, Anna, et al.
Publicado: (2020)

Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers
por: Roy, Harekrishna, et al.
Publicado: (2013)

Preparation and in vitro release kinetics of ivermectin sustained-release bolus optimized by response surface methodology
por: Ruan, Xiangchun, et al.
Publicado: (2018)

Development and Characterization of Novel Floating-Mucoadhesive Tablets Bearing Venlafaxine Hydrochloride
por: Misra, Raghvendra, et al.
Publicado: (2016)

Formulation and evaluation of sustained release matrix tablet of rabeprazole using wet granulation technique
por: Khan, Ruqaiyah, et al.
Publicado: (2014)

Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet
por: Kadivar, Ali, et al.
Publicado: (2015)

Development and Evaluation of Sustained Release Tablet of Betahistine Hydrochloride Using Ion Exchange Resin Tulsion T344
por: Wagh, Vijay D., et al.
Publicado: (2012)

Optimization of Nasal Liposome Formulation of Venlafaxine Hydrochloride using a Box-Behnken Experimental Design
por: Khute, Sulekha, et al.
Publicado: (2023)

Formulation and evaluation of sustained release bioadhesive tablets of ofloxacin using 3(2) factorial design
por: Gangurde, Hemant H, et al.
Publicado: (2011)

Formulation and evaluation of rifampicin sustained release tablets using juice of Citrus limetta as bio-retardant
por: Gaur, K. Pawan, et al.
Publicado: (2012)

Formulation and In-vitro Characterization of Sustained Release Matrix Type Ocular Timolol Maleate Mini-Tablet
por: Mortazavi, Seyed Alireza, et al.
Publicado: (2014)

Poly(curcumin β-amino ester)-Based Tablet Formulation for a Sustained Release of Curcumin
por: Patil, Vinod S., et al.
Publicado: (2022)

Correction: Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet
Publicado: (2022)

Formulation, optimization and evaluation of sustained release microsphere of ketoprofen
por: Prajapati, Chirag V., et al.
Publicado: (2012)

Formulation and Evaluation of a Sustained-Release Tablets of Metformin Hydrochloride Using Hydrophilic Synthetic and Hydrophobic Natural Polymers
por: Wadher, K. J., et al.
Publicado: (2011)

Formulation Optimization of Hydrodynamically Balanced Oral Controlled Release Bioadhesive Tablets of Tramadol Hydrochloride
por: Singh, Bhupinder, et al.
Publicado: (2010)

Formulation of Lipid-Based Tableted Spray-Congealed Microparticles for Sustained Release of Vildagliptin: In Vitro and In Vivo Studies
por: Al Zahabi, Khaled H., et al.
Publicado: (2021)

Venlafaxine extended release (XR) in the treatment of panic disorder
por: Kjernisted, Kevin, et al.
Publicado: (2007)

Formulation and Evaluation of Fixed-Dose Combination of Bilayer Gastroretentive Matrix Tablet Containing Atorvastatin as Fast-Release and Atenolol as Sustained-Release
por: Dey, Sanjay, et al.
Publicado: (2014)

Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery
por: Schlesinger, Erica B., et al.
Publicado: (2018)

Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation
por: Mohamed, Mohamed-Eslam F., et al.
Publicado: (2019)

VENLAFAXINE-INDUCED MANIA
por: Jagadheesan, K., et al.
Publicado: (2001)

Venlafaxine besylate monohydrate
por: Corvalan, Carolina H., et al.
Publicado: (2013)

Influence of Formulation Factors and Compression Force on Release Profile of Sustained Release Metoprolol Tablets using Compritol(®) 888ATO as Lipid Excipient
por: Patere, Shilpa N., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a98vect751gqtnnesp7jlfatu9